Actively Recruiting
CAPA In-vitro Oocyte Maturation for Female Infertility
Led by Chinese University of Hong Kong · Updated on 2025-12-08
100
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying in vitro oocyte maturation (IVM), a gentler assisted reproductive technology, in women facing infertility. This approach may be especially helpful for patients with polycystic ovary syndrome (PCOS) or those seeking fertility preservation due to treatments like chemotherapy. The study aims to explore the benefits of IVM, including its lower health risks and reduced costs compared to traditional ovarian stimulation methods. The study evaluates CAPA-IVM, a procedure where eggs mature outside the body, unlike classical IVF where ovarian stimulation affects the patient directly. This method avoids the typical risks and burdens associated with systemic ovarian stimulation. Participants will undergo the CAPA-IVM procedure, focusing on egg maturation outside the body without hormonal treatments. Participants will be monitored for the number of mature eggs obtained one week after the procedure. The study involves women and girls up to 50 years old who are seeking fertility preservation or oocyte retrieval services. Researchers will assess outcomes related to egg maturity while ensuring safety and minimizing patient burden throughout the process. The total study duration extends until May 2032.
CONDITIONS
Brief Title
CAPA In-vitro Oocyte Maturation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged from 0 to 50 years old
- Patients seeking fertility preservation services
- Patients seeking oocyte retrieval services
You will not qualify if you...
- Patients unable to provide consent or assent due to significant psychiatric problems or cognitive delay
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 week
Participants undergo CAPA In-vitro Oocyte Maturation, where oocytes are treated and matured outside the woman's body without systemic ovarian stimulation.
1 treatment visit
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
P
Pui Wah Jacqueline Chung
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here